Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Impact of growth factors in the regulation of apoptosis in low-risk myelodysplastic syndromes.

Medical oncology (Northwood, London, England) - 1 Jan 2006

Tehranchi R

Abstract excerpt

Increased apoptosis of hematopoietic progenitors is a hallmark of myelodysplastic syndromes (MDS) and results in ineffective hematopoiesis. Erythroid apoptosis is thought to be the main mechanism underlying the severe anemia observed in the low-risk subgroups, refractory anemia (RA) and RA with ringed sideroblasts (RARS). Treatment with erythropoietin (Epo) alone or in combination with granulocyte...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Apoptosis
Share to Cell Differentiation
Share to DNA, Mitochondrial

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Erythropoietin

Share to Ferritins

Share to Granulocyte Colony-Stimulating Factor

Share to Hematopoiesis

Share to Myelodysplastic Syndromes

Source

Identifiers

PMID: 16645228
DOI: 10.1385/MO:23:1:137

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Impact of growth factors in the regulation of apoptosis in low-risk myelodysplastic syndromes.PMID 16645228Read ↗

Apoptosis and its role in the myelodysplastic syndromes: implications for disease natural history and treatmentSemantic proximity Read ↗

Apoptosis in patients with myelodysplastic syndromes: differential involvement of marrow cells in ‘good’ versus ‘poor’ prognosis patients and correlation with apoptosis-related genesSemantic proximity Read ↗

Apoptosis and antiapoptotic mechanisms in the progression of myelodysplastic syndromeSemantic proximity Read ↗

Novel insights into the biology of myelodysplastic syndromes: excessive apoptosis and the role of cytokines.Semantic proximity Read ↗

Expression and prognostic significance of Bcl‐2 family proteins in myelodysplastic syndromesSemantic proximity Read ↗

Ineffective erythropoiesis in myelodysplastic syndromes: correlation with Fas expression but not with lack of erythropoietin receptor signal transductionSemantic proximity Read ↗

Strategies for biology- and molecular-based treatment of myelodysplastic syndromes.Semantic proximity Read ↗

‘Low‐risk’ myelodysplastic syndrome is associated with excessive apoptosis and an increased ratio of pro‐ versus anti‐apoptotic bcl‐2‐related proteinsSemantic proximity Read ↗

Blockade of BCL-2 proteins efficiently induces apoptosis in progenitor cells of high-risk myelodysplastic syndromes patientsSemantic proximity Read ↗

Apoptosis, bcl-2 expression and p53 accumulation in myelodysplastic syndrome, myelodysplastic-syndrome-derived acute myelogenous leukemia and de novo acute myelogenous leukemia.Semantic proximity Read ↗

Luspatercept (RAP-536) modulates oxidative stress without affecting mutation burden in myelodysplastic syndromes.Semantic proximity Read ↗

miR-378 inhibits cell growth and enhances apoptosis in human myelodysplastic syndromesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.